We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
CureVac has won approval in Germany and Belgium for a phase 1 trial of its COVID-19 vaccine, just days after the German government announced it was acquiring a 23 percent stake in the company. Read More
Regulators, drugmakers and researchers need to work in parallel to speed development of COVID-19 vaccines and treatments and prepare for the hurdles still to come, a former FDA commissioner advised. Read More
Cosmaceutical Research Lab was hit with an FDA warning letter for serious violations uncovered during an inspection of the firm’s manufacturing facility in British Columbia, Canada. Read More
Trump administration officials announced yesterday that 300 million doses of a COVID-19 vaccine should be available by January 2021 under Operation Warp Speed although they stressed there’s no guarantee that a vaccine will be available by then. Read More
The University of Oxford’s RECOVERY trial has found that a cheap and widely available steroid provides a benefit in COVID-19 patients and should become standard of care in patients sick enough to require oxygen. Read More
In a move to lessen India’s dependence on imports, the government is offering incentives to increase domestic manufacturing for certain drug starting materials, intermediates and active pharmaceutical ingredients (APIs). Read More
Eli Lilly has begun enrolling patients for a phase 3 trial of its rheumatoid arthritis treatment Olumiant (baricitinib) for hospitalized COVID-19 patients. Read More